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ABSTRACT
Background: Historically, patients with cancer have been perceived as poor candidates for ICU
admission. General ICU admission criteria lists cancer patients as low priority in ICU admission
depriving them of the care they rightfully deserve. The purpose of this literary synthesis was to
examine ICU admission criteria, risk factors, and outcomes of ICU admission in relation to
hematological and solid tumor cancers and discuss ways that practitioners and nurses can
educate patients with cancer and their families on appropriateness of ICU care.
Methods: A total of 768 articles were found in a literature search including all literature from
2005 to 2016 from all countries using the databases CINAHL Plus, MEDLINE, PsycINFO, and
Academic Search Premier. These were further narrowed down based on relevancy by topic or
reading abstracts. A total of 13 articles utilizing the inclusion and exclusion criteria of the
literature search were included in the final literature synthesis.
Results: In addition to general ICU admission criteria several other criteria and scores can be
helpful in admitting patients with cancer to the ICU including cancer specific criteria, mortality
predictor tools, performance status, and ICU trials. Mortality predictors, in combination with
other patient characteristics, demonstrated effectiveness to predict outcomes in patients with
cancer. Survival rates in hematological and solid tumor cancers have improved from the past,
and lower prognostic scores can predict who will have better outcomes.
Conclusion: Cancer specific criteria, mortality predictor tools, performance status, and ICU trials
in addition to general ICU criteria should be used for admission of cancer patients into ICU.
Practitioners and nurses should become familiar with the newest outcomes in patients with
cancer to make collaborative informed decisions about ICU admission.
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INTRODUCTION
Background and Significance
Intensive care units (ICU) were developed in the 1960s and flourished in the 1970s with
the implementation of trauma management techniques and resuscitation standards. These units
served severe physiologically unstable patients who needed technical or artificial life support
(Egol et al., 1999). Originally, intensive care was limited to specific populations and focused
solely on care for cardiac, surgical, and trauma patients and care available only in ICU included
endotracheal mechanical ventilation, noninvasive mechanical ventilation, vasopressive agents,
and dialysis (Darmon et al., 2005). However, many other patients with chronic medical disorders
needed the medical resources available only in ICU settings (Shelton, 2010).
ICU care is more frequent and intense, focusing on monitoring and treating
hemodynamic instability that cannot be provided on the general medical, surgical, or progressive
units. The availability of ICU specified care led to increased demand for these resources. The
increased demand for ICU services posed a financial challenge to hospital administrators who
were tasked with effectively and efficiently managing operations. Administrators met this
challenge by establishing strict admission criteria for the ICU so that the limited ICU resources
could be allocated effectively (Egol et al., 1999).
There is a growing need for intensive care support in the cancer population due to
complications from cancer and aggressive cancer treatments (Caruso et al., 2010; McCaughey,
Blackwood, Glackin, Brady, & McMullin et al., 2013). Today, patients with cancer are surviving
longer due to major advances in screening, early diagnosis, and treatment options. The American
Cancer Society (ACS) estimates that there will be 1.7 million new cancer diagnoses in the United
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States in 2016 and that 595,690 people will die from cancer that same year (American Cancer
Society, 2016). However, the overall mortality rate for cancer has declined over the past 2
decades and this consistent decline has averted more than 1.7 million deaths from cancer. These
statistics highlight that, today, people are surviving longer with cancer, and some of them may
benefit from advanced support during this time (American Cancer Society, 2016).
While cancer treatment was once limited to the surgical removal of tumors in the early
stages of the disease, antineoplastic drug therapy demonstrated major response rates in the late
1970s, especially in Hodgkin's disease, testicular cancer, and childhood leukemia. However,
complications from hematologic and solid tumor malignancies may require admission into ICU
prior to cancer therapy initiation (Darmon et al., 2005). Today, the main reasons for ICU
admission in this population are infections and organ failure involvement, frequently occurring
in combination (Darmon et al., 2005; Hull & O’Rourke, 2007). Additionally, the organ
dysfunction and myelosuppression that result from therapies like blood and bone marrow
transplantation have increased the need for intensive care beds (Shelton, 2010).
And yet, a cancer diagnosis was once considered a contraindication for an ICU admission
(Egol et al., 1999; Shelton, 2010). Historical and preexisting views by internists concerning
patients with cancer needing ICU treatment had long been “What is the point?” (Smith &
Wigmore, 2008, p. 91). In the 1980s and 1990s, published studies demonstrated very poor
survival rates, especially in patients with neutropenic hematology cancer in the ICU (Smith &
Wigmore, 2008). Similarly, for patients with cancer, outcomes of treatment in the ICU was
difficult to determine at time of admission. Paz, Crilly, Weiner, & Brodsky (1993) studied post
bone marrow transplant patient admissions into a medical ICU and found that adults with cancer
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who required mechanical ventilation while in the ICU had a discharge rate of only 3.7%
compared to 81.3% in patients with cancer who did not need this therapy.
While the need for specific ICU admission criteria for patients with cancer is known,
there is only minimal evidence of actual cancer specific criteria and outcomes. In 1983, the
National Institutes of Health (NIH) led the first consensus conference on critical care medicine.
At this conference, NIH first advocated for the need to expand ICU admission criteria from the
ICU concept first defined in the 1960s. Recommendations for predetermined admission criteria
is one way to allocate scarce resources when triaging patients (Egol et al., 1999).
In ideal conditions, ICU admission would rely solely on the factor of the patient’s benefit
from its care. In a less than ideal world, individual patient benefit is hard to define, especially at
time of admission for patients with cancer. The concepts of “too well to benefit” and “too sick to
benefit” are two conditions where ICU care was once considered to provide no greater benefit
than conventional care. However, determining ICU care benefit in these two populations is
difficult because severely ill and unstable patients have also been shown to improve after ICU
care (Egol et al., 1999; McCaughey et al., 2013). Admission into ICU should be based on clinical
judgement in combination with standardized tools assessing severity of illness and prognosis in
the critically ill (Egol et al., 1999).
Prioritization is one model currently used to decide who is appropriate for admission into
the general ICU. The Prioritization model triages based on highest patient benefit from ICU
admission. The Prioritization model guidelines may be used as the initial triage for ICU
admission in combination with Diagnosis and Objective Parameter models. Triaging is important
when the need for ICU beds outnumber the availability of ICU beds (Egol et al., 1999).
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The prioritization model of ICU admission guidelines also includes patients who are
generally inappropriate for ICU admission. A limitation of this model is that patients with
terminal and irreversible illness facing imminent death, such as patients with advanced cancer
unresponsive to chemotherapy/radiation therapy, are denied ICU admission (Egol et al., 1999).
This is unfortunate because mortality in patients with cancer is chiefly due to the number and
nature of organ failures, not stage or nature of malignancy itself (Azoulay et al., 2011). These
organ failures have the potential to be reversed or managed with appropriate and early ICU care.
Purpose of Paper
The lack of concrete evidence about who is appropriate for admission to the ICU, especially in
patients with cancer, highlights the need for further exploration of this topic. The goal of this
thesis is to examine the literature related to ICU admission and outcomes for patients with
cancer. The specific aims of this literature synthesis are to: 1) Evaluate current ICU admission
criteria and examine how patients with cancer fit into this criteria. 2) Examine risk factors and
outcomes of ICU admission in relation to hematological cancer and solid tumor cancers. 3)
Discuss ways that practitioners can educate patients with cancer and their families on
appropriateness of ICU care.
Currently, the high cost of ICU resources has been a major determinant that, in general,
the ICU should be reserved for reversible medical conditions in which patients have a chance for
substantial recovery. This policy has the potential to exclude patients with cancer who may
benefit from ICU care. A better understanding of current ICU outcomes in relation to cancer
admission risk factors and ICU treatments could help guide appropriate ICU admission and
restriction criteria for patients with cancer (Egol et al., 1999). Understanding post ICU care
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survival rates, may provide practitioners and nurses to help their patients with cancer make
informed medical care decisions.
Methods
A review of current literature was conducted using 4 databases: CINAHL Plus,
MEDLINE, PsycINFO, and Academic Search Premier. Key words used in the search were
intensive care unit, ICU, critical care, intensive care, patient admission, admission care,
admission, criteria, triage, standards, decision making, outcomes, prognosis, neoplasms, and
cancer.
The inclusion criteria included publications of review articles, quantitative and qualitative
research from 2005-2016. The search included peer reviewed articles from all countries focused
on cancer admission and outcomes of adult oncology population (age greater than 18 years) in
the ICU setting. Exclusion criteria: the pediatric oncology population (age less than 18 years),
articles not in English, not human participants, no abstract available, no full text available.
A total of 768 articles were found at the conclusion of the full literature search process
conducted on 3/10/16 (refer to appendix B for figure of literature search method). The total 768
articles included 383 Medline articles, 275 Academic Search Premier articles, 89 CINAHL Plus
articles, and 21 Psych INFO articles. The articles in each of these databases were further
narrowed down by discarding articles that were not relevant by title of article to the topics of
ICU, cancer, admission, and outcomes.
This process reduced the total to 86 articles: 33 Medline articles, 23 Academic Search
Premier articles, 25 CINAHL Plus articles, and 5 Psych INFO articles. Abstracts and articles
were read and references of these articles were reviewed, further exclusion by hand was done to
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limit to topics of general and cancer specific admission criteria, cancer outcomes with focus on
hematological and solid tumors, ICU trial, and prognostic scores, resulting in a final count of 13
articles used in this literature analysis. Refer to appendix C table 4 for concise presentation of
studies.
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FINDINGS
ICU Admission Criteria for Patients with Cancer
Current admission into the ICU for patients with cancer is based on general ICU criteria,
which includes the combination of Prioritization, Diagnosis, and Objective Parameters models.
Clearly defined admission and triage criteria can provide access to effective treatment for
critically ill patients in need of ICU resources (Egol et al., 1999).
General ICU admission criteria
Guidelines for ICU admission were developed and published by the Society of Critical Care
Medicine (SCCM) in 1999. The SCCM recommends that an intensivist led multi-professional
team should be involved in developing and implementing the unit-specific admission protocol
from the existing guidelines; emphasis is placed on collaboration with nursing and ancillary staff.
The SCCM recommends that admission to the intensive care unit be based on using models of
Prioritization, Diagnosis, and Objective Parameters (Egol et al., 1999).
The Prioritization model, which practitioners should use as the initial triage decision
making point for patients needing ICU support, is organized based on what type of patients
would benefit most from an ICU admission. Patients are organized into one of four categories.
The larger the priority number (1 to 4), the lower the probability of admission into ICU (Egol et
al., 1999).
Priority 1, the highest probability of admission into ICU, includes critically ill and
unstable patients that need treatments not available outside the ICU. Priority 2 includes patients
requiring continuous intensive monitoring and may require ICU treatments. Priority 3 includes
critically ill and unstable patients with reduced chances of survival due to underlying disease or
7

acute illness. In priority 3, therapeutic limits are placed on cardiopulmonary resuscitation(CPR)
and intubation. Priority 4, the lowest probability of admission into the ICU, includes patients
who are too well or too sick to benefit from ICU care (Egol et al., 1999).
Categories 1 and 2 are admitted to the ICU. Category 3 is assessed individually, and
category 4 should not be admitted to the ICU (Egol et al., 1999). A more detailed explanation of
the prioritization model can be found on Table 1 in appendix A.
The Diagnosis model, which practitioners should use to supplement the Prioritization
model for patients needing ICU support, also guides practitioners by organizing conditions and
diseases appropriate for ICU admission under individual organ specific and non-organ specific
categories. Individual patient diagnoses are taken into account when prioritizing the patient for
ICU admission (Egol et al., 1999).
The major organ systems addressed under the Diagnosis model are pulmonary,
cardiovascular, neurologic, gastrointestinal, and endocrine. Surgical, drug overdose, and
“miscellaneous” are non-organ specific categories (Egol et al., 1999). A comprehensive list of
the Diagnosis model can be found on Table 2 in appendix A.
Using Objective Parameters model is the final recommendation for making decisions
about ICU admission. Objective parameters include physical exam, vital signs, laboratory values,
radiography, and electrocardiogram (EKG) findings. Even though these objective parameters
were generated by consensus through a review process done by the Joint Commission on
Accreditation of Healthcare Organizations, no data exists demonstrating improved outcomes
from specific criteria levels alone (Egol et al., 1999). A comprehensive list of the Objective
Parameters model can be found on Table 3 in the appendix A.
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Cancer specific admission criteria
When following the general ICU admission criteria patients with cancer fall under
priority 3 and 4 of the Prioritization model. However, they may periodically have an acute
condition that puts them into a higher priority category. For example, a patient in acute
respiratory failure needing ventilator support normally falls under priority one, but in patients
with metastatic cancer, they automatically become priority 3 (Egol et al., 1999).
Falling into priority 3 limits the types of life saving treatments available in the ICU that
patients with cancer can receive, for instance CPR and intubation. Falling into category 4 denies
patients with cancer ICU care for the sole reason of having a metastatic disease unresponsive to
treatments and only calls for individual patient review in exceptional cases (Egol et al., 1999).
This is problematic because they may have a reversible condition that could be treated
with ICU care, but their underlying cancer diagnosis would prevent them from being admitted to
the ICU for that care. This is why it is important to also consider cancer specific guidelines in
these patients when making admission decisions.
Shelton (2010) outlined two guidelines that tried to define objective parameters focused
on patients with cancer: Groeger and Aurora’s broad categories and the Australian classification
system. Under the Broad Category model, the cancer specific criteria for ICU admission are 1)
postoperative care, 2) medical emergencies management due to cancer or cancer treatment, and
3) hemodynamic monitoring during oncologic treatments. Groeger and Aurora’s categories also
take into account the likelihood of meaningful survival, respecting patient wishes, and
distributive justice with limited ICU beds (Shelton, 2010).
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The cancer specific criteria for the Australian Classification System considers patients
who may have: 1) a newly diagnosed cancer, 2) the possibility of a cure, 3) control of their
disease, 4) benefit from supportive care needed due to treatment failure, and 5) benefit from
palliative care symptom control. Based on this system the only patients with cancer that are
denied ICU admission outright are patients who have elected to receive palliative care only
(Shelton, 2010).
Cancer progresses at different rates in individuals, this is why individual patient
evaluation for ICU admission is necessary in this population of patients (McCaughey et al.,
2013). While there is consensus on the benefits of ICU admission using these additional criteria,
there is limited research based evidence on improved outcomes using these criteria.
Mortality predictor tools
Mortality predictor tool, can also help practitioners make ICU admission decisions.
Variables affecting mortality predicting tools include, but are not limited to, short term organ
compromise, chronic immune suppression, previous organ insult, and prior health. Even with all
the difficulty in using these mortality predictor tools, these tools can be fairly accurate in the
prediction of mortality in critically ill patients with cancer in the ICU (Kopterides et al., 2011).
Knowledge of prognostic scores, including short and long term prognosis is essential to act as a
guideline for ICU admission in patients with cancer (Caruso et al., 2010).
Mortality predictor tools, also referred to as prognostic scores, for ICU admission include
the Acute Physiology and Chronic Health Evaluation(APACHE I, II, III), and the shortened
version of this called the Simplified Acute Physiology Score(SAPS II). The APACHE II uses
patient data to produce a severity of illness score at ICU admission and 24-48 hours later. The
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degree of organ failure is then used to predict mortality with the help of an equation. A
modification of this model to account for oncological variables led to the development of the
Intensive Care Mortality Model (ICMM) (Shelton, 2010).
The ICMM’s poor performance in patients with sepsis lead to further development of
tools that incorporated organ failures to determine mortality. This resulted in the development of
the following mortality predictive models: 1) Logistic Organ Failure (LOD), 2) Sequential Organ
Failure Assessment (SOFA), and 3) Multiple Organ Dysfunction Score (MODS) (Shelton, 2010).
Since the number of organ dysfunctions is a better predictor of mortality in patients with
cancer than the underlying cancer alone, these tools became useful in determining ICU need and
benefit. In her extensive history of mortality predicting tools, Shelton did not come to a
conclusion in regards to which was best for use as part of ICU admission criteria in patients with
cancer (Shelton, 2010).
Kopterides et al. (2011) studied outcomes of using mortality predicting tools in patients
with cancer admitted into ICU. Whereas previous studies had looked at the use of these scoring
systems in general ICU populations, this study focused on comparing the APACHE II, SAPS II,
and SOFA prognostic scoring systems in patients with cancer. This study included 126 patients.
The most critical values, obtained within 24 hours of ICU admission, in hematologic and solid
tumor malignancies were used to calculate the APACHE II, SAPS II, and SOFA scores. The
higher the scores, the worse the prognosis. Overall, an ICU mortality rate of 46.8%, with a
median duration of the ICU stay of 6 days (5 days for patients needing mechanical ventilation)
was reported.
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Other factors that were unfavorably associated with ICU survival were being bedridden
(poor patient performance status), receiving chemotherapy in the previous month, septic shock,
organ failures, or aggressive supportive care (mechanical ventilation, vasopressors, and renal
replacement therapy). They found that APACHE II, SAPS II, and SOFA were all good
predictors of mortality in patients with cancer. APACHE II was predictive of 76.3% of nonsurvivors and 86.6% of survivors. SAPS II was predictive of 69.5% of non-survivors and 83.6%
of survivors. SOFA was predictive of 62.7% of non-survivors and 83.6% of survivors. They also
noted that combining scores of SOFA and SAPS II with variables not part of the calculated
score, such as patient performance status and presence of septic shock, infection, or anemia,
resulted in prognostic models with improved calibration and discrimination (Kopterides et al.,
2011).
Performance status
Another scoring system that can be used during the ICU admission process is the
performance status of the patient prior to admission. This scoring system is called Eastern
Cooperative Oncology Group-Performance Status score (ECOG-PS). This score measures a
cancer patient’s general well-being and daily activity level on a scale from 0-5, with 0 being
asymptomatic and 5 being dead (Chou et al., 2012). Multiple studies have found benefits
combining scores of SOFA and SAPS II with variables not part of the calculated score, such as
patient performance status (Kopterides et al., 2011).
ICU trial
An alternative to using formalized admission criteria to the ICU is an ICU trial of 3 to 5
days. This trial calls for unlimited ICU support for a limited time, followed by reevaluation
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(Lecuyer et al., 2007; Azoulay et al., 2011). This gives practitioners and patients another choice
than direct ICU denial in patients with cancer and allows them to see if ICU care is necessary
and beneficial. ICU trials may also provide patients and families a sense of support and relief of
guilt that all available resources were used for the benefit of the patient. ICU trials can also be a
time where palliative care can be discussed in further detail with patients and families (Lecuyer
et al., 2007).
Lecuyer et al. (2007) studied outcomes of ICU trials for patients with cancer requiring
mechanical ventilation. Their study included 188 patients that would normally not have been
admitted into ICU based on General ICU admission criteria alone. Patients were given full-code
management with reappraisal on day 6 for continuing or discontinuing the full use of all
available ICU resources.
Results showed a 40% survival rate for mechanically ventilated patients with cancer in
the ICU at day 5 and a 21% overall survival rate. Of the 188 participants, 85 died before their
fifth day in ICU and 54 died after their fifth day in ICU. They also noted that initial data
available at the time of ICU admission was not significantly different between survivors and
non-survivors who received at least 5 days of the ICU trial. Based on the results found in their
study, Lecuyer et al. (2007) advocated for ICU trial with full-code ICU management and
reappraisal on day 6 for all patients with cancer (excluding bedridden, palliative care only, and
patient refusal of ICU treatment) who do not meet current ICU admission criteria.
Outcomes in Oncology Patients Needing ICU Care
Practitioners should be familiar with recent outcomes in patients with cancer post ICU
care. Understanding risk factors for ICU admission and outcomes post ICU care should provide
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practitioners with the ability to make more objective decisions on what patients are most
appropriate for ICU care on individual assessments. Understanding risk factors also enables
practitioners with the ability to get patients appropriate ICU treatments as early as possible.
Patients with cancer should have access to the lifesaving treatments in ICU and be treated
with the same courtesy as other patients who are referred for ICU admission. Risk factors that
should be considered include, but are not limited to, being bedridden, receiving chemotherapy in
the previous month, mechanical ventilation, renal treatments, or multi-organ failure (McCaughey
et al., 2013).
Hematological/oncological outcomes
In the past 2 decades, hematology/oncology patients admitted into ICU had mortality
rates of 54%-98% (Geerse et al., 2011; McCaughey et al., 2013). Today, survival rates for some
hematological malignancies exceed 80% (McCaughey et al., 2013)
McCaughey et al. (2013) examined the characteristics and outcomes of haematological
patients with cancer admitted to the intensive care unit. This study included 21 patients admitted
into ICU for hematological malignancy. The most common risk factor for admission in these
patients was acute respiratory failure secondary to sepsis with a median length of ICU stay of 4
days.
Results showed that the ICU mortality rate in leukemia and lymphoma patients was 43%
at 3 months, and 67% at 6 months. This challenges the preconception that patients with cancer
are inappropriate for ICU admission. The median number of failed organs in this study was 2.25
to 3. Fungal infections and bone marrow transplant (BMT) were adverse predictors of outcomes
in this population (McCaughey et al., 2013).
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Geerse et al. (2011) explored the prognosis of patients with haematological malignancies
admitted to the intensive care unit and investigated SOFA and APACHI II scores’ ability to
predict mortality. This study included 75 patients suffering from hematological malignancy. The
only exclusion criteria used, in this study, was patients with do not resuscitate (DNR) orders.
Results of their study found ICU survival rate of 44% and in-hospital survival rate of 35%.
Geerse et al. (2011) found that APACHE II and SOFA were reliable predictors of
mortality, but were not absolute predictors. Mortality was significantly higher in patients with
higher APACHE II and SOFA scores and those who received mechanical ventilation within 24
hours of ICU admission. It was also higher in patients treated with ionotropic/vasopressor
therapy and in patients who needed CPR. They also found that 33% of the survivors in their
study had SOFA score ≥ 15. They concluded that high SOFA score is not an absolute predictor
of mortality, however, increasing SOFA score throughout ICU admission was significantly
associated with increased mortality.
Geerse et al. (2011) also looked at individual risk factors for ICU admission in relation to
patient survival outcomes. The most common risk factors for admission were respiratory failure
and sepsis. Others were heart failure, post resuscitation, and neurological. The survival rates for
the risk factors were: 67% for neurological, 54% for heart failure, 50% for post resuscitation,
43% for respiratory failure, and 37% for sepsis.
These numbers were all relative to the number of patients admitted for each risk factor,
and it is important to note that these outcomes were seen in hematological patients with cancer
who are traditionally thought to have poorer outcomes than solid tumor cancers. This supports
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the assertion that it is not the cancer itself but the acute complications and organ failures that are
more predictive of outcomes.
Solid tumor outcomes
Mortality in patients with cancer is chiefly due to the number and nature of organ
failures, not stage or nature of malignancy itself (Azoulay et al., 2011; Kopterides et al., 2011;
Geerse et al., 2011). Therefore, metastatic solid cancer diagnosis itself should not exclude
patients from ICU admission.
Caruso et al. (2010) were the first to evaluate short and long term survival of metastatic
solid tumor cancers admitted into ICU due to an emergency. This study included 83 patients.
They found a 1 year survival rate of 55.4% and a 2 year survival rate of 12%. They came to the
conclusion that survival rates in patients with metastatic solid cancers admitted to the ICU were
low, but mirror rates of other patients with cancer admitted to the ICU. They noticed that higher
SAPS II score and lower platelet count (thrombocytopenia) on admission were associated with
poorer outcomes.
Caruso et al. (2010) also concluded that no sole characteristic of metastasis (number of
organ metastasis or central nervous system involvement) affected mortality, so this should not be
an exclusion criteria for ICU admission in patients with cancer. Short term outcomes were
associated with the acute disease presentation and not with the underlying malignancy itself.
Chou et al. (2012) looked at outcomes of ICU admission in patients with stage III and IV
lung cancer. All patients with stage III or IV lung cancer were included. No restrictions were
placed on ICU admission. Chou et al. (2012) looked at outcomes for sepsis related acute
respiratory failure needing invasive mechanical ventilation in patients with cancer, and reported
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a 41.4% survival rate. Patients that died in this study had poor performance status, lower serum
albumin level, higher percentage of disseminated coagulation(DIC), and higher SOFA scores.
The mortality predictor tool, SOFA was the only independent predictor of mortality on
multivariate analysis, p value = 0.026. They concluded that patients with late stage lung cancer
with sepsis-related respiratory failure that presented with lower SOFA scores (5.9 ± 2) seemed to
have relatively good outcomes and may benefit from ICU care.
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DISCUSSION
Factors that should play a role in the ICU admission process are general ICU criteria,
cancer specific criteria, mortality predictor tools, and patient performance status prior to ICU
admission. The aforementioned factors in conjunction with ICU trials should be considered
instead of immediate refusal of ICU care in patients with cancer.
Shelton (2010) suggests that ICU practitioners do not necessarily use admission
guidelines in daily practice. As many as 75% do not adhere to their own admission criteria, and
79% do not have restriction criteria. This has been supported by local practitioners. Dr. Patty
Geddie, an Oncology Clinical Nurse Specialist and Ms. Jenny Edwards an Oncology PCU
charge nurse, who state that no formal written criteria currently exists for admission of patients
with cancer into ICU at our local hospitals (P. Geddie, personal communication, May 11, 2016;
J. Edwards, personal communication, June 12, 2016).
In these hospitals when there is suspicion about the need for ICU care in an oncology
patient, a specialized team called a rapid response team comes to evaluate the patients for ICU
admission based on the patient’s current status and the clinical experience of the health care
providers. Eventually the decision for ICU admission falls into the hands of the ICU
practitioner/physician (P. Geddie, personal communication, May 11, 2016; J. Edwards, personal
communication, June 12, 2016).
While this shows that a collaborative effort is already being made between nurses and
practitioners, clinical judgement and experience by itself can lead to bias in patient selection for
ICU. Basing ICU admission decisions solely on clinical judgement in patients with cancer can
prove to be misleading, since, traditionally, patients with cancer have been viewed as poor
18

candidates for ICU admission (Kopterides et al., 2011). Not using admission criteria, especially
in patients with cancer who already face a disadvantage to admission, can deprive these patients
of the care that they deserve.
This review looked at outcomes for hematological and solid tumor cancers and found that
survival rates post ICU care in these patients have improved from values found in the past.
Several factors that significantly resulted in poorer outcomes in patients with cancer admitted
into ICU included thrombocytopenia, low albumin levels, DIC, or chemotherapy within the
month prior to admission (Chou et al., 2012).
Through the reviewed studies, and in discussion with oncology nurses, it was concluded
that one of the most common reasons for patients with cancer to need ICU resources is for the
treatment of sepsis that most often results in respiratory failure and hemodynamic instability (P.
Geddie, personal communication, May 11, 2016; J. Edwards, personal communication, June 12,
2016). Also, patients with non-acutely reversible lung injury that had early invasive ventilation
had better outcomes than NIMV failure followed by later invasive intubation (Chou et al., 2012).
Currently there is no debate in treating sepsis with antibiotics in patients with cancer, ICU
treatments for respiratory failure should be no different.
Each of the studies reviewed used at least one mortality predicting tool and, while there
was no consensus on which tool is a better predictor of outcomes, several of the studies found
that combining the mortality predictor tools with other patient characteristics, like performance
status, produced better outcome predictions.
The most commonly mentioned predictor tools in the studies reviewed were the
APACHE II, SAPS II, SOFA, and LOD scores. There is a general trend that higher the mortality
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predictor score the worse the patient outcome will be. A contradiction to this general trend was
the study done by Geerse et al. (2011) where 30% of the survivors in the study had a SOFA score
≥ 15, but they noted increasing SOFA scores (≥2 points) during ICU care, had higher mortality
than patients with unchanged or decreasing SOFA scores.
The ideal course of admission for patients with cancer in need of ICU care is a
combination of general ICU criteria, cancer specific criteria, mortality predictor tools,
performance status and ICU trials. McCaughey et al. (2013) stressed the importance of flexible
admission criteria and importance of individualized patient selection, advocating for individual
case by case selection for admission due to the excess mortality found in patients considered too
well for ICU admission and the relative good survival rates found in patients considered too sick
for ICU care. As such, ICU trials should be considered instead of immediate refusal of ICU care
in patients with cancer.
These trials would give patients with cancer full access to ICU resources for a limited
amount of time with reassessments to see if such care is beneficial. Reassessments during ICU
trials are essential in these patients because they are likely to suffer from acutely reversible organ
failures due to treatments and acute cancer complications.
Shelton (2010), recommended the use of many factors in the admission process of
patients with cancer, and Lecuyer et al. (2007), also recommended the use of ICU trials in
patients with cancer. Both supported the conclusion that mortality predictor tools play an
essential role in ICU trials reassessments, helping in the determination to continue or withdraw
full ICU support.
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IMPLICATIONS
Nursing Implications
Nurses share in the responsibility for ensuring patients with cancer have access to the best
available care, whether by taking an active role in pain management, early infection recognition
and control, providing emotional support to their patient, or by acting as liaisons between
patients and practitioners. Nurses can play a powerful role in the care of patients with cancer by
advocating for patient education and the inclusion of patients and families in the ICU admission
process.
Educating patients and families, imparting knowledge about all aspects of ICU care being
offered and knowledge of the consequences of such care, can help diffuse stressful situations
when a patient’s health deteriorates. It can also reduce the hopelessness that patients and families
feel when they believe everything possible is not being done for their loved one. This will
empower patients and families with the ability to make informed decisions for themselves.
Active communication between practitioners, nurses, patients, and families can lead to improved
collaborative decisions for appropriate ICU use and reduction of waste in limited ICU resources.
Research Implications
More research will also be beneficial in the areas of ICU trials, performance status scores
and mortality predictor tools in relation to patients with cancer in ICU. There is currently no
consensus on which tools are the best to use in patients with cancer. This can produce different
outcomes at different hospitals depending on which tool they use in the overall ICU admission
and care process.

21

Researchers are exploring long and short term outcomes but there is no general consensus
of times frames in relation to short and long term outcomes. In some studies, the short term
outcomes might be described at 1 month while in another the short term outcome might be 1
year. Further work is needed to classify time frames for short and long term outcomes to make
more correlative decisions based on outcomes.
Several limitations also play significant roles in the research of ICU care in patients with
cancer. Most of the studies have small sample sizes, done at individual hospitals, and are
retrospective convenience sample chart reviews. More prospective randomized studies are
needed incorporating large sample sizes and multiple hospitals.
Also, many studies exploring this topic are done outside the United States, it is essential
that more research be done in the United States to test for similar outcomes and evaluate issues
that are unique to the United States.
Currently, most of the research, in this area, is still being conducted by doctors. More
collaborative work including active participation of nurses, respiratory therapists, nutritionists,
and social workers is appropriate and necessary for this type of research.
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Table 1: Prioritization Model
 Critically ill and unstable patients that require intensive treatments and
monitoring only available in ICU.
 Examples of the needed treatments include ventilator support, continuous
monitoring, continuous vasopressor infusions, continuous drug titration…
 No therapeutic limits of ICU care placed on these patients
 Patient examples include acute respiratory failure requiring mechanical
ventilator support, shock or hemodynamically unstable patients receiving
invasive monitoring and/or vasopressor treatments…
Priority 2
 Patients requiring intensive monitoring and at some point may need
immediate intervention.
 No therapeutic limits of ICU care placed on these patients.
 Patient examples include acute severe medical or surgical complications
worsening chronic comorbid conditions.
Priority 3
 Critically ill and unstable patients with reduced likelihood of recovery due
to nature of acute illness or underlying disease.
 May receive intensive treatment to relieve acute illness.
 Therapeutic limits such as no intubation or cardiopulmonary resuscitation.
 Patient examples include metastatic malignancy complicated by airway
obstruction, infection, or cardiac tamponade.
Priority 4 These patients are placed into category A or Category B.
 Category A: Little or no anticipated benefit from ICU care versus nonICU care. These patients are considered too well to benefit from ICU care.
 Category B: Terminal and IRREVERSIBLE illness facing death. These
patients are considered too sick to benefit from ICU care.
 Not appropriate for ICU admission
 Patient examples include metastatic cancer unresponsive to chemotherapy
and/or radiation therapy, patients declining ICU care/invasive monitoring
and choosing instead comfort care only through informed consent…
Note: Adapted from Guidelines for ICU admission, discharge, and triage by the Society of
Critical Care Medicine.
Reference
Egol, A., Fromm, R., Guntupalli, K. K., Fitzpatrick, M., Kaufman, D., Nasraway, S., ...
Zimmerman, J . (1999). Guidelines for intensive care unit admission, discharge, and
triage. Critical Care Medicine, 27(3), 633-638.
Priority 1
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Table 2: Diagnosis Model
 Acute respiratory failure needing intubation or ventilatory support
 Respiratory deterioration in non-ICU floor
 Pulmonary emboli with hemodynamic instability
 Continuous nursing/respiratory monitoring and care
 Massive hemoptysis
 Etc.
Cardiac
 Acute myocardial infraction with complications
 Cardiogenic shock
 Acute congestive heart failure with respiratory failure and/or
requiring hemodynamic instability
 Hypertensive emergencies
 Etc.
Neurologic
 Acute stroke or altered mental status
 Coma
 Etc.
Gastrointestinal
 Life threatening gastrointestinal bleed
 Fulminant hepatic failure
 Severe pancreatitis
 Etc.
Endocrine
 Diabetic ketoacidosis complicated by respiratory insufficiency,
altered mental status, hemodynamic instability, or severe acidosis.
 Thyroid storm or myxedema coma with hemodynamic instability
 Hyperosmolar state with coma and/or hemodynamic instability
 Adrenal crisis with hemodynamic compromise
 Severe uncontrolled hypercalcemia with altered mental status
 Etc.
Surgical
Post operation patients requiring hemodynamic monitoring/ventilatory
support or continuous monitoring
Drug Overdose Drug ingestion resulting in significantly altered mental status with
inadequate airway protection
Etc.
Miscellaneous
Septic shock with hemodynamic instability
New/experimental therapies with potential for complications
Etc.
Note: Adapted from Guidelines for ICU admission, discharge, and triage by the Society of
Critical Care Medicine.
Reference
Egol, A., Fromm, R., Guntupalli, K. K., Fitzpatrick, M., Kaufman, D., Nasraway, S., ...
Zimmerman, J . (1999). Guidelines for intensive care unit admission, discharge, and
triage. Critical Care Medicine, 27(3), 633-638.
Pulmonary
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Table 3: Objective Parameters Model
 Heart rate(HR) < 40 beats/minute
 HR > 150 beats/minute(min)
 Respiratory rate(RR) > 35breaths/min
 Systolic arterial pressure: A or B
A. <80 millimeter of mercury(mmHg)
B. 20mmHg below patient’s normal
 Etc.
New Laboratory Values
 PO2<50
 PH <7.1 or >7.7
 Serum calcium >15
 Toxic drug levels
 Etc.
Radiography/Ultrasonography
 Dissecting aortic aneurism
 Etc.
Electrocardiogram(EKG)
 Myocardial infraction(MI) with
complex arrhythmias, hemodynamic
instability or congestive heart
failure(CHF)
 Sustained ventricular tachycardia or
ventricular fibrillation
 Etc.
Acute Physical Findings
 Airway obstruction
 Anisocoria in unconscious patient
 Anuria
 Status epilepticus
 Cardiac tamponade
 Etc.
Note: Adapted from Guidelines for ICU admission, discharge, and triage by the Society of
Critical Care Medicine.
Reference
Egol, A., Fromm, R., Guntupalli, K. K., Fitzpatrick, M., Kaufman, D., Nasraway, S., ...
Zimmerman, J . (1999). Guidelines for intensive care unit admission, discharge, and
triage. Critical Care Medicine, 27(3), 633-638.
Vital Signs
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Figure 1: Selection Method of Literature
Databases used: CINAHL Plus, MEDLINE, PsycINFO, and Academic Search Premier
(MH "Intensive Care Units") OR "ICU" OR "Critical Care" OR "Intensive Care" OR (MH "Critical
Care")

Limiter used: 2005-2016

Total articles found 342,442
AND (MH "Patient Admission") OR (MH "Admission Care(Iowa NIC)") OR admission*"
Total articles found 38,537
AND Criteria Or Triage OR Standards OR "'Decision Making" OR Outcomes OR Prognosis
Total articles found 21,056
AND (MH "Neoplasms+") OR "Cancer*"
Total articles found 2,004
NOT Pediatric* OR Child*
Limiters used: Peer reviewed, English language, human participants, abstract available, full text available
Total articles found 768
AND Hand reviewed by individual databases
Limiters used: topic relevant to ICU, cancer, admission and outcomes
Total articles found 86
Further hand reviewed and looked at references of studies
Limiters used: Topic and abstract relevant to general or cancer specific admission criteria, cancer
outcomes with focus on hematological or solid tumors, ICU trial, or prognostic scores
Total number of articles found 13
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Table 4: Table of Evidence
Inclusion criteria: 2005-2016, peer reviewed, English language, human participants, abstract available, full text available, all countries.
Exclusion criteria: Pediatrics (<18 years old), not English, not relevant to literature analysis by article topic or abstract.
Article

Country

Purpose

Sample
size

Study design

Intervention

Results/ Key Findings

Nursing
Implication

Azoulay, Soares,
Darmon, Benoit,
Pastores &
Afessa (2011)

France

To increase the
ability of cancer
patients to
receive ICU
care.

None

Consensus
opinion from
experts, review

None

Short term survival
after critical care
improved. Improved
understanding in organ
dysfunction in cancer
patients has led to
improved survival.

Better
outcomes in
cancer today so
need for ICU
care.

Brazil

To look at short
and long term
survival of
metastatic solid
tumor cancers.

83
patients
over 1
year

Retrospective
chart analysis

None,
observational

Survival rates in
patients with metastatic
solid cancers mirror
rates of other cancers
post ICU treatment.
Higher SAPS II score
and lower platelet
count(thrombocytopeni
a) associated with
poorer outcomes.
No sole characteristic of
metastasis by self is a
predictor for mortality.

Metastasis
itself is not a
predictor of
death, so ICU
admission
decisions
should not only
rely on this.
One of the few
studies to look
at 1 and 2-year
survival post
ICU treatment

“Intensive care
of the cancer
patient: Recent
achievements
and remaining
challenges”
Caruso, Ferreira,
Laurienzo,
Titton, Terabe,
Carnieli &
Deheinzelin
(2010)
“Short- and longterm survival of
patients with
metastatic solid
cancer admitted
to the intensive
care unit:
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Article
Prognostic
factors”
Chou, Chen, Su,
Hung, Hsiao,
Tseng, ... Perng
(2012)
“Hospital
outcomes for
patients with
stage III and IV
lung cancer
admitted to the
intensive care
unit for sepsisrelated acute
respiratory
failure”
Darmon, Thiery,
Ciroldi, Miranda,
Galicier,
Raffoux, ...
Azoulay (2005)
“Intensive care in
patients with
newly diagnosed
malignancies and
a need for cancer
chemotherapy”

Country

Purpose

Sample
size

Study design

Intervention

Results/ Key Findings

Taiwan

To look at
outcomes in
stage III and IV
patients with
lung cancer
admitted into
ICU.

70
patients
over 1
year

Retrospective
chart analysis

None,
observational

SOFA was the only
independent predictor
of mortality on
multivariate analysis, p
value = 0.026). They
concluded that patients
with late stage lung
cancer with sepsisrelated respiratory
failure that presented
with lower SOFA
scores (5.9 ± 2) seemed
to have better outcomes
and may benefit from
ICU care.

France

To determine if
patients with
newly diagnosed
cancer and
organ failure
need ICU
admission and
immediate
chemotherapy.

100
patients,
done
over 6
years

Prospective
observational
cohort study

None

Mortality is chiefly due
to number of organ
failures not nature of
malignancy.
40% mortality after 30
days and 51% after 180
days, these results
suggest that advanced
cancer at diagnosis
should not be reason for
ICU denial. They also
found that
administering
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Nursing
Implication
in cancer
patients.
SOFA
mortality
predictor tool
can be helpful
in making
better decisions
about ICU
admission in
patients with
cancer.

Important to
note organ
failures and not
the cancer itself
predicts
mortality.

Article

Egol, Fromm,
Guntupalli,
Fitzpatrick,
Kaufman,
Nasraway, S., ...
Zimmerman
(1999)

Country

United
States

Purpose

Sample
size

Study design

Intervention

To provide ICU
guidelines for
admission,
discharge, and
triage of adult
patients.

None

Guidelines
formed by
Society of
Critical
Care Medicine

None,
statement of
guidelines

To investigating
SOFA and
APACHI II
scores ability to
predict mortality
of patients with

75
patients,
done
over 7
years

Chart review
retrospective
cohort study

None,
observational

“Guidelines for
intensive care
unit admission,
discharge, and
triage”

Geerse, Span,
The
Sietsma, & Mook Netherlan
(2011)
ds
“Prognosis of
patients with
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Results/ Key Findings
chemotherapy during
ICU treatment is
doable.
The Society of Critical
Care Medicine(SCCM)
recommends that an
intensivist led multiprofessional team
should be involved in
developing and
implementing the unitspecific admission
protocol from the
existing guidelines.
Collaboration with
nursing and ancillary
staff is recommended.
The SCCM
recommends that
admission to the
intensive care unit be
based on using models
of Prioritization,
Diagnosis, and
Objective Parameters.
APACHE II and SOFA
were reliable predictors
of mortality, but are not
absolute predictors.
Concluded that high
SOFA score is not an

Nursing
Implication

Nurses should
be involved in
the admission
process of
patients into
the ICU. The
admission
process should
be a
collaborative
effort
consisting of
all types of
health care
providers.

Important to
note not just an
initial high
SOFA score
but increasing
SOFA score

Article
haematological
malignancies
admitted to the
intensive care
unit: Sequential
organ failure
assessment
(SOFA) trend is
a powerful
predictor of
mortality”
Hull, &
O’Rourke
(2007)
“Oncologycritical care
nursing
collaboration:
Recommendation
for optimizing
continuity of care
of critically Ill
patients with
cancer”
Kopterides,
Liberopoul,
Llias, Anthi,
Pragkastis,
Tsangaris,
...Dimopoulou

Country

Purpose

Sample
size

Study design

Intervention

haematological
malignancies
admitted to the
intensive care
unit.

Results/ Key Findings

Nursing
Implication

absolute predictor of
mortality, however,
increasing SOFA score
throughout ICU
admission was
significantly associated
with increased
mortality.

throughout ICU
admission was
significantly
associated with
increased
mortality.

United
States

To promote
continuity of
care through
communication
between
oncology nurses
and critical care
nurses.

None

Recommendati
ons, review

None

Collaborative
relationship building
between oncology nurse
and ICU nurse helps
with continuity of care
in patients with cancer
needing ICU care. The
sharing of oncology
specific knowledge can
reduce mortality and
morbidity.

Collaborative
effort is needed
in the care of
cancer patients
in the ICU.

Greece

To compare the
effectiveness of
APACHE II,
SAPS II, and
SOFA
prognostic

126
patients,
done
over 3
years

Prospective
observational
cohort study

None

General prognostic
models are predictive of
mortality in patient with
cancer in the ICU.
Outcome prediction
tools are not perfect

General
prognostic
models can
help in the
process of
admission and
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Article

Country

(2011)
“General
prognostic scores
in outcome
prediction for
cancer patients
admitted to the
intensive care
unit”
Lecuyer,
Chevert, Thiery,
Darmon,
Schlemmer, &
Azoulay (2007)
“The ICU trial: A
new admission
policy for cancer
patients requiring
mechanical
ventilation”

Purpose

Sample
size

Study design

Intervention

scoring systems
in patients with
cancer.

France

To evaluate the
ICU trial as a
new admission
policy
for cancer
patient requiring
mechanical
ventilation with
at least one
other organ
failure.

188
patients,
over 3
years

Prospective
interventional
cohort study
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711 patients
referred for
ICU admission
over a 3 year
period. Out of
these 188
patients were
included in the
ICU trial.
Excluded
bedridden and
palliative care
only patients.
Patients were
given full-code
management
with
reappraisal on
day 6 for
continuing or
discontinuing

Results/ Key Findings

Nursing
Implication

preadmission tools for
ICU, but can help in
telling current patient
status and in informing
patients and families
about prognosis.

care of patients
with cancer in
the ICU.

Recommend ICU trial
with full code
management and
reappraisal on day 6 in
all non-bedridden
patients with cancer
who are not on
palliative care. Found
that day 6 is most
predictive of mortality
when using prognostic
scores rather than when
it is done earlier during
ICU care.

ICU trials can
be used in
patients that do
not meet
general ICU
admission
criteria.
Decisions to
withdraw full
ICU support
when doing
and ICU trial
should not take
place prior to
day 6 because
this is time then
mortality
predictor tool
has best
predictive
ability.

Article

McCaughey,
Blackwood,
Glackin, Brady
& McMullin
(2013)

Country

“Outcomes of
patients requiring

Sample
size

Study design

United
Kingdom

To profile
outcome of adult
hematological
oncology
patients
admitted into
ICU.

21
patients,
done
over 1
year

Chart review
retrospective
cohort study

United
States

To compare
outcomes of
BMT patients
requiring and
not requiring
invasion

36
patients,
done
over 6
years

Chart review
retrospective
cohort study

“Charateristics
and outcomes of
haematology
patients admitted
to the intensive
care unit”

Paz, Crilley,
Weiner &
Brodsky
(1993)

Purpose
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Intervention
the full use of
all available
ICU resources.
None

None

Results/ Key Findings

Nursing
Implication

ICU mortality rate in
leukemia and
lymphoma patients was
43% at 3 months, and
67% at 6 months. This
challenges the
preconception that
patients with cancer are
inappropriate for ICU
admission. The median
number of failed organs
in this study was 2.25 to
3. Fungal infections and
bone marrow transplant
(BMT) were adverse
predictors of outcomes
in this population.

Patients with
hematological
cancer today
have better
outcomes then
in the past so
this should be
considered in
decisions for
ICU admission.
Practitioners
and nurses
should be
updated on the
newest
outcomes to
make
appropriate
patient
decisions.

Adults with cancer who
required mechanical
ventilation while in the
ICU had a discharge
rate of only 3.7%
compared to 81.3% in
patients with cancer

Invasive
mechanical
ventilation may
be a poor
predictor of
outcome.

Article

Country

medical ICU
admission
following bone
marrow
transplantation”

Shelton (2010)
“Admission
criteria and
prognostication
in patients with
cancer admitted
to the intensive
care unit”

Purpose

Sample
size

Study design

Intervention

mechanical
ventilation.

United
States

To look at
cancer specific
guidelines for
ICU admission
in patients with
cancer.

None

Review
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None

Results/ Key Findings

Nursing
Implication

who did not need this
therapy. Multiple organ
failure was seen in 3 of
the 12 survivors and in
20 of the 24 nonsurvivors.
Concluded there is high
chance of survival
without and reasonable
chance of survival with
invasive mechanical
ventilation.
Outlined two guidelines
that tried to define
objective parameters
focused on patients with
cancer: Groeger and
Aurora’s Broad
categories and the
Australian classification
system.

Multiple organ
failure
development is
associated with
higher
mortality.

Incorporation
of cancer
specific
guidelines into
the Objective
Parameters
model of
general ICU
admission will
provide for
improved
decision
making
abilities in
patients with
cancer in
relation to ICU
care.

Article

Country

Purpose

Sample
size

Study design

Intervention

Results/ Key Findings

Nursing
Implication

Smith &
Wigmore, (2008)

United
Kingdom

To look at
outcome in ICU
patients with
cancer.

None

Review

None

Internists concerning
patients with cancer
needing ICU treatment
had long been What is
the point? In the 1980s
and 1990s, published
studies demonstrated
very poor survival rates,
especially in patients
with neutropenic
hematology cancer in
the ICU.

Individual
patient
selection is
needed for ICU
admission.
Understanding
current
outcomes will
help in
admission
decisions.

“Outcomes of
cancer patients in
critical care”
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